Effect of Low Volume Sprint Interval Training on Cardiorespiratory Fitness
Part of paid clinical trials in San Marcos, California.
- Sponsor
- California State University, San Marcos
- Study ID
- NCT07328568
- Status
- Recruiting
Conditions
- Healthy Participants
- Inactivity, Physical
- Overweight (BMI > 25)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- High intensity interval training — OTHERParticipants will complete 24 sessions of REHIT and their responses will be compared to a non exercising control group.
Study Details
Low levels of physical activity (PA) are related to poor health and greater risk of premature death in adults. Lack of time is cited as a primary barrier to partaking in PA. In the last 20 years, a lot of attention has been directed towards the efficacy of high intensity interval training (HIIT), which consists of brief, intense bursts of PA separated by recovery. One primary benefit of HIIT is a sizable increase in cardiorespiratory fitness (CRF), which enables adults to exercise better and reduce health risks due to the strong link between health status and CRF. Completion of cardiovascular exercise is typically recommended for all adults to increase CRF, yet it takes a lot of time and may be perceived as boring. Alternatively, HIIT requires less time and tends to cause greater feelings of enjoyment in many adults. Hundreds of studies report an increase in CRF in response to HIIT in various groups of adults ranging from athletes and those with obesity, diabetes, cancer, stroke, and even spinal cord injury, which emphasizes the potency of this vigorous form of PA. Yet, many studies are weakened by a small sample size which questions the feasibility of these findings. This randomized controlled trial will test the efficacy and feasibility of a very small amount of HIIT, referred to as reduced exertion high intensity interval training (REHIT), in inactive adults. In the proposed study, REHIT will consist of 2 days per week of 1 to two 10 - 20 second sprints on a stationary bike. The proposed sample will include 60 adults who complete 18 sessions of REHIT over a 9 week period, and their responses will be compared to a non exercising control group. During the study, changes in CRF, fuel metabolism, and psychological responses will be monitored, with the latter outcome shedding light on the overall feasibility of HIIT in inactive adults. Overall, this novel study has profound public health applications as it will assess fitness and health related changes to a small dose of PA in the largest sample to date. If substantial changes in CRF are shown, these data have the potential to modify public health guidelines for implementing PA in inactive adults.
Key Dates
- First listed
- Jan 9, 2026
- Start date
- Nov 5, 2025
- Status verified
- Aug 2026
- Primary completion
- Jun 1, 2028
- Completion
- Sep 1, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Intervention groupThis group will perform long term REHIT.
- Placebo Comparator: Non exercising control groupThis group will not complete REHIT, and will be given the option to complete the training once post testing is performed.
Primary Outcome Measure
Cardiorespiratory fitness [ Time Frame: CRF will be assessed at baseline 48 - 72 hours before the start of training, and at 6 and 12 weeks of training, which represent halfway and end of training. The assessments will be performed at least 24 hours after sessions of exercise training. ]
Central Contacts
- Todd A Astorino, Ph.D760750-7351
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| California State University--San Marcos Human Performance Laboratory | San Marcos | California | 92096 | Todd A Astorino, Ph.D Todd Anthony Astorino, Ph.D (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Marcos, CA
Related Studies
- Natural History Study of and Genetic Modifiers in Spinocerebellar AtaxiasRecruiting · Lauren Moore · Los Angeles, California
- A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)PHASE1 · Recruiting · Equilibra Bioscience LLC · Los Angeles, California
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsPHASE1 · Recruiting · Pfizer · Anaheim, California
- A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy VolunteersPHASE1 · Not Yet Recruiting · AstraZeneca · Glendale, California